Five-Year Post-Injection Results of the Phase 3 Trial of Voretigene Neparvovec-rzyl in Biallelic RPE65 Mutation-Associated Inherited Retinal Disease

被引：0
|
作者：
Bennett, Jean [1 ,2 ]
Russell, Stephen R. [3 ]
High, Katherine A. [4 ]
Drack, Arlene V. [3 ]
Yu, Zi-Fan [5 ]
Chung, Daniel C. [4 ]
Reape, Kathy [4 ]
Maguire, Albert M. [1 ,2 ]
机构：
[1] Childrens Hosp Philadelphia, Ophthalmol, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Ophthalmol, Philadelphia, PA 19104 USA
[3] Univ Iowa, Iowa City, IA USA
[4] Spark Therapeut Inc, Philadelphia, PA USA
[5] Stat Collaborat Inc, Washington, DC USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2021年 / 62卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3540
引用
收藏
页数：3
相关论文
共 27 条
  • [1] Voretigene neparvovec-rzyl for the treatment of biallelic RPE65 mutation-associated retinal dystrophy
    Russell, Stephen
    Bennett, Jean
    Maguire, Albert M.
    High, Katherine A.
    EXPERT OPINION ON ORPHAN DRUGS, 2018, 6 (08): : 457 - 464
  • [2] Five-year update for the Phase III voretigene neparvovec study in biallelic RPE65 mutation-associated inherited retinal disease
    Leroy, Bart P.
    Russell, Stephen R.
    Bennett, Jean
    High, Katherine A.
    Drack, Arlene V.
    Yu, Zi-Fan
    Chung, Daniel
    Reape, Kathleen Z.
    Maguire, Albert M.
    Simunovic, Matthew
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 49 (08): : 966 - 967
  • [3] Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy Results of Phase 1 and 3 Trials
    Maguire, Albert M.
    Russell, Stephen
    Wellman, Jennifer A.
    Chung, Daniel C.
    Yu, Zi-Fan
    Tillman, Amy
    Wittes, Janet
    Pappas, Julie
    Elci, Okan
    Marshall, Kathleen A.
    McCague, Sarah
    Reichert, Hannah
    Davis, Maria
    Simonelli, Francesca
    Leroy, Bart P.
    Wright, J. Fraser
    High, Katherine A.
    Bennett, Jean
    OPHTHALMOLOGY, 2019, 126 (09) : 1273 - 1285
  • [4] Four-year results for the phase 3 voretigene neparvovec (VN) study in biallelic RPE65 mutation-associated inherited retinal disease
    Chung, Daniel
    Russell, Stephen
    Bennett, Jean
    High, Katherin A.
    Drack, Arlene
    Yu, Zi-Fan
    Reape, Kathleen Z.
    Maguire, Albert M.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 47 : 138 - 138
  • [5] Three-year update for the phase 3 voretigene neparvovec study in biallelic RPE65 mutation-associated inherited retinal disease
    Russell, Stephen R.
    Bennett, Jean
    Wellman, Jennifer
    Chung, Daniel C.
    High, Katherine
    Yu, Zi-Fan
    Tillman, Amy
    Maguire, Albert M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [6] Three-year update for the phase 3 voretigene neparvovec study in biallelic RPE65 mutation-associated inherited retinal disease
    van den Born, L. Ingeborgh
    Russell, S.
    Bennett, J.
    Chung, D.
    Maguire, A. M.
    ACTA OPHTHALMOLOGICA, 2018, 96 : 28 - 28
  • [7] Voretigene Neparvovec: A Review in RPE65 Mutation-Associated Inherited Retinal Dystrophy
    Kang, Connie
    Scott, Lesley J.
    MOLECULAR DIAGNOSIS & THERAPY, 2020, 24 (04) : 487 - 495
  • [8] Voretigene Neparvovec: A Review in RPE65 Mutation-Associated Inherited Retinal Dystrophy
    Connie Kang
    Lesley J. Scott
    Molecular Diagnosis & Therapy, 2020, 24 : 487 - 495
  • [9] Prospect of retinal gene therapy following commercialization of voretigene neparvovec-rzyl for retinal dystrophy mediated by RPE65 mutation
    Ameri, Hossein
    JOURNAL OF CURRENT OPHTHALMOLOGY, 2018, 30 (01): : 1 - 2
  • [10] Year 2 results for a phase 3 trial of voretigene neparvovec in biallelic RPE65-mediated inherited retinal disease
    Russell, Stephen R.
    Bennett, Jean
    Wellman, Jennifer A.
    Chung, Daniel C.
    High, Katherine A.
    Yu, Zi-Fan
    Tillman, Amy
    Maguire, Albert M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
123